COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY
COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY
批准号:
2057610
负责人:
Robert D. Harrington
金额:
$8.09万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1997-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Research. Expression of the HIV-I receptor CD4 on many non-human and see
human cell lines is not sufficient to permit HIV-I infection. The
investigator describes human glioblastoma cell line (U373) which remains
resistant to HIV-1 despite the added expression of an authentic CD4
molecule. The block to H1V- 1 infection of these cells is strain-
independent and appears to be at viral entry. Heterokaryons of CD4-
expressing U373 (U373-CD4) cells fused to HeLa cells allow HIV-I entry. A
U373-CD4\HeLa hybrid clone allows efficient HIV-I replication. These
results suggest that HeLa cells express a factor(s) that can complement the
viral entry defect of U373-CD4 cells and which is necessary for efficient
HIV-l infection. Experiments that test the ability of additional human cell
lines to complement U373-CD4 cells will provide insight into the complexity
of the viral entry process. Studies to identify the chromosome encoding the
complementing gene and the gene itself will help define the cellular
requirements for CD4-mediated HIV-l infection and may provide new targets
for interrupting the viral life cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytotoxic immunoconjugates to deplete persistent HIV reservoirs
-
批准号:10305666
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2017
-
负责人:Robert D. Harrington
-
依托单位:
Cytotoxic immunoconjugates to deplete persistent HIV reservoirs
-
批准号:10062853
-
项目类别:
-
资助金额:$83.47万
-
财政年份:2017
-
负责人:Robert D. Harrington
-
依托单位:
COFACTOR REQUIREMENT FOR CD4-MEDIATED HIV-1 ENTRY
-
批准号:2057611
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1994
-
负责人:Robert D. Harrington
-
依托单位:
Clinical Research and Retrovirology (CRRC)
-
批准号:8520674
-
项目类别:
-
资助金额:$37.05万
-
财政年份:--
-
负责人:Robert D. Harrington
-
依托单位:
海外基金